Price To Earnings Ratio 23.79 | Sector PE 69.47 |
PB Ratio 15.15 | Sector PB 9.32 |
EPS 262.13 | Dividend Yield 2.07 |
Today's Volume 14.792 K | 5 Day Avg. Volume 11.644 K |
PEG Ratio 0.08 | Market Cap. ₹ 14,720.00 Cr. |
Time | SANOFI | VS | Industry |
---|---|---|---|
1 Day | -0.3% | 0.19% | |
1 Week | 2.66% | 3.31% | |
1 Month | -6.49% | 0.92% | |
6 Months | -24.68% | 22.41% | |
1 Year | -15.95% | 48.28% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 6139.39 | Bullish |
20 | 6196.81 | Bullish |
30 | 6287.66 | Bearish |
50 | 6495.91 | Bearish |
100 | 6610.2 | Bearish |
200 | 7213.05 | Bearish |
Annual | FY 2023 | FY 2004 | FY 2003 | ||||
---|---|---|---|---|---|---|---|
Operating Activities | 230.40 | 84.96 | 81.76 | ||||
Investing Activities | 37.50 | 2.23 | -21.60 | ||||
Financing Activities | -878.30 | -42.00 | -44.82 | ||||
Net Cash Flow | -610.40 | 45.20 | 15.35 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Sanofi India | -0.3 | 2.66 | -6.49 | -24.68 | -15.95 |
Alembic | 1.66 | 6.55 | 4.98 | 2.76 | 2.76 |
Aurobindo Pharma | 0.39 | 3.15 | -9.87 | -7.14 | 16.99 |
Fortis Healthcare | 2.25 | 10.82 | 13.14 | 42.21 | 81.43 |
Ajanta Pharmaceuticals | 0.27 | -1.65 | -3.39 | 19 | 46.25 |
Sanofi India Limited is a healthcare company. The company's field of activity is the production and trade of drugs and medicines. It offers a variety of medications and supplements for diabetes (both insulin and oral), cardiology, thrombosis, epilepsy, allergies and infections. It has two manufacturing facilities, one in Hyderabad and the other in Goa. Its geographic segments include India, Singapore and others. It sells its products through independent distributors mostly in India. It also manufactures its products through third party manufacturers. Different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, ointments and creams. Its brands include Lantus, Allegra and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer health products include Allegra, Allegra nasal and Avil.